Net sales $16,900 $12,417 $31,745 $23,213
Cost of goods sold 6,610 5,545 12,507 10,098
Gross profit 10,290 6,872 19,238 13,115
Operating expenses:
Sales and marketing 7,147 6,115 13,634 12,038
Research and
development 2,302 1,901 4,508 3,558
In-process research
and development - 3,500 - 3,500
General and
administrative 2,764 2,491 5,768 5,107
Amortization of
intangibles 890 414 1,781 829
Intangible asset
impairment - 755 - 755
Total operating
expenses 13,103 15,176 25,691 25,787
Operating loss (2,813) (8,304) (6,453) (12,672)
Interest expense, net (657) (307) (1,276) (752)
Other income (expense),
net (1,040) (105) 878 (111)
Net loss before income
taxes (4,510) (8,716) (6,851) (13,535)
Income tax expense (159) (1) (229) (2)
Net loss ($ 4,669) ($ 8,717) ($7,080) ($13,537)
Net loss per share:
Basic and diluted ($0.08) ($0.18) ($0.12) ($0.30)
Weighted average
number of shares
outstanding:
Basic and diluted 60,018 49,406 59,877 45,749
ATS Medical, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
June 28, December 31,
2008
'/>"/>
| SOURCE ATS Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |